Results 181 to 190 of about 3,237,470 (329)
WASOG Clinical Trial Endpoint Task Force: Executive Summary. [PDF]
Baughman RP +4 more
europepmc +1 more source
Mechanically Stable and Tunable Photoactivated Peptide‐Based Hydrogels for Soft Tissue Adhesion
A collagen‐like peptide hydrogel platform is developed using supramolecular self‐assembly and light‐triggered crosslinking. It creates mechanically stable, tunable hydrogels with cytocompatibility and biodegradability, making them potential soft tissue adhesives.
Alex Ross +8 more
wiley +1 more source
China Stroke Prevention and Control Report 2024: An executive summary. [PDF]
National Program for Stroke Prevention and Million Disability Reduction Initiative Expert Committee.
europepmc +1 more source
Child Care Expansion Initiative: Ripple Effect Mapping: October 2013 Executive Summary
Kit Alviz, Tonia Renee Durden
openalex +1 more source
Collecting Societies Codes of Conduct: Executive Summary
Benedict Atkinson, Brian Fitzgerald
openalex +1 more source
xxxx. ABSTRACT Glioblastoma (GBM) remains one of the most lethal brain cancers, with median survival rarely exceeding 15 months after diagnosis. Interleukin‐12 (IL‐12) is a potent immunostimulatory cytokine capable of reshaping the tumor microenvironment (TME), yet its clinical translation is hindered by systemic toxicity and short half‐life. RNA‐based
Fatima Hameedat +11 more
wiley +1 more source
Iplom is an Italian company operating in the energy and oil sector. As a Seveso company, Iplom has worked with specialist service companies like TECSA to improve the Safety Report over time. They have gone beyond just meeting formal requirements and have
Luca Fiorentini, Gianfranco Peiretti
doaj

